The objective of the MAGBBRIS Project is to enhance ischemic tissue remodelling by encapsulating EPCs-secretome into biocompatible nanocapsules labelled with  magnetic nanoparticles and fluorescent tags, allowing magnetic guidance and retention, simultaneous in vivo imaging and controlled release.

MAGBBRIS is funded within the framework of the EuroNanoMed III Joint Transnational Call
by the following National Founding Agencies:

Euronanomed3 logo

December 13, 2019

Alba Grayston was the winner in the pre-doctoral category of the poster session in the 13th annual Scientific Meeting at Vall d'Hebron Research Institute. The poster entitled ‘Intraarterial administration of Endothelial...

November 18, 2019

The French Society for the Study of Blood-Brain Interfaces (SEISC) conducted their 2019 Annual Meeting at CEA-Service hospitalier Frédéric Joliot in Orsay the 15th of November.

Rodrigo Azevedo Loiola, postdoctoral fellow...

Please reload


MAGBBRIS is a highly multidisciplinary consortium integrated by 6 partners from 5 European countries, involved in materials-science, biomedical and clinical research and industrial partnership. 




4th of February 2020


31st of March 2020

​MAGBBRIS Annual Meeting

Milano, IT

5-6h of May 2020